Human Immunodeficiency Virus  >>  stavudine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

14 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
stavudine / Generic mfg.
NCT00116116: DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Completed
4
70
US
efavirenz, stavudine extended release, lamivudine
Bristol-Myers Squibb
HIV Infections, AIDS
06/05
06/05
NCT00005017: Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Unknown status
4
300
US
Ritonavir, Abacavir sulfate, Amprenavir, Efavirenz, Lamivudine, Stavudine
Glaxo Wellcome
HIV Infections
 
 
NCT00005106: A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Completed
4
230
US
Lamivudine/Zidovudine, Abacavir sulfate, Nelfinavir mesylate, Lamivudine, Stavudine
Glaxo Wellcome
HIV Infections
 
 
NCT00005000: Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Unknown status
4
200
US
Nelfinavir mesylate, Efavirenz, Lamivudine, Keyhole-Limpet Hemocyanin, Stavudine, Zidovudine, Didanosine
Agouron Pharmaceuticals
HIV Infections
 
 
NCT00235222: Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY

Unknown status
4
57
Europe
stavudine
Groupe Hospitalier Pitie-Salpetriere, Bristol-Myers Squibb
HIV
 
03/06
NCT00055120: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Completed
4
283
US, RoW
Emtricitabine/tenofovir disoproxil fumarate, Lopinavir/ritonavir, Stavudine
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections, AIDS-Related Opportunistic Infections
09/06
08/07
NCT00618176: Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

Completed
4
198
RoW
Zidovudine (AZT)+ Didanosine (ddI)+ Nevirapine (NVP), Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP), Zidovudine (AZT), Lamivudine (3TC), Nevirapine (NVP)
Peking Union Medical College, Ministry of Science and Technology of the People´s Republic of China
HIV Infections
09/06
 
NCT00342355: Antiretroviral Therapy for Advanced HIV Disease in South Africa

Completed
4
1771
RoW
Zidovudine, AZT, Stavudine, D4T, Didanosine, DDI, Lamivudine, 3TC, Efavirenz, EFV, Lopinavir/Ritonavir, Kaletra
National Institutes of Health Clinical Center (CC)
HIV
03/08
08/08
NCT01601899: Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients

Terminated
4
60
RoW
Stavudine, Lamivudine (3TC) 150mg po BD, PLUS, Efavirenz 600mg po nocte, Tenofovir
University of Witwatersrand, South Africa
Mitochondrial Toxicity, Metabolic Complications
10/10
12/10
2010-023749-30: Studio PKCT - Pharmacokinetics of chemotherapy when given concurrently with antiretroviral (Protocol no. CSL01). Studio PKCT – Farmacocinetica dei chemioterapici antitumorali quando somministrati in concomitanza con antiretrovirali (Protocollo nr. CSL01).

Completed
4
12
Europe
Solution for injection, Film-coated tablet, Tablet, Coated tablet, Capsule, hard, Gastro-resistant capsule, hard, Powder and solvent for solution for injection, Capsule, soft, DOXORUBICINA EBEWE*1F 50MG/25M, ISENTRESS*FL 180CPR RIV 400MG, INTELENCE*FL 120CPR 100MG, ZIAGEN*6BLISTER 10CPR 300MG, ZERIT*56CPS 30MG, ZERIT*56CPS 40MG, VIREAD*30CPR 245MG, VIDEX*30CPS GASTR 250MG, VIDEX*30CPS GASTR 400MG, TRUVADA*30CPR RIV 200MG/245MG, RETROVIR*60CPR 300MG, KIVEXA*BL 30CPR RIV 600MG+300M, FUZEON*SC 60FL POLV 90MG/ML, TELZIR*1FL 60CPR RIV 700MG, NORVIR*FL 84CPS MOLLI 100MG, REYATAZ*60CPS 200MG, PREZISTA*120CPR RIV 300MG, KALETRA*120CPR RIV 200MG+50MG, INVIRASE*FL 120CPR RIV 500MG, APTIVUS*FL 120CPS MOLLI 250MG, CELSENTRI*30CPR RIV 300MG, COMBIVIR*60CPR RIV 150MG+300MG, EMTRIVA*1BLIST 30CPS 200MG, EPIVIR*FL 30CPR RIV 300MG, VIRAMUNE*60CPR 200MG, SUSTIVA*30CPR RIV 600MG BLIST
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
patients with Hodgkin lymphoma and non-Hodgkin's lymphoma and HIV infection. pazienti affetti da linfoma Hodgkin e non Hodgkin e infezione da HIV.
 
 
NCT01694017: Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy

Completed
4
68
RoW
Tenofovir, Atripla, Vonavir, Zidovudine, Lazid-N, Duovir-N, Zidolam-N
Tufts University, Christian Medical College, Vellore, India
HIV
08/14
08/14
2004-001403-35: Estudio abierto, multicéntrico y aleatorizado sobre la eficacia y seguridad de la reducción de dosis de estavudina en pacientes en tratamiento antirretroviral que incluye estavudina a dosis estándar con buen control virológico e inmunológico.

Ongoing
4
284
Europe
Zerit, Zerit, Zerit, Zerit
Doctor Pere Domingo
AIDS
 
 
2012-000198-21: A study to assess the efficacy and safety of the withdrawal of nucleos/tide analogues with resistance in multitreated HIV-1-infected subjects with virological suppression ESTUDIO SOBRE LA EFICACIA Y SEGURIDAD DE LA RETIRADA DE ANÁLOGOS DE NUCLEÓS/TIDO CON RESISTENCIA EN SUJETOS CON INFECCIÓN POR VIH-1 MULTITRATADOS Y CON SUPRESIÓN VIROLÓGICA.

Ongoing
4
292
Europe
Epivir, Emtriva, Retrovir, Zerit, Viread, Ziagen, Combivir, Trizivir, Kivexa, Truvada, Videx, Epivir, Emtriva, Retrovir, Zerit, Viread, Ziagen, Combivir, Trizivir, Kivexa, Truvada, Videx
Fundació Lluita contra la SIDA, Ministerio de Sanidad, Política Social e Igualdad (Investigación Independiente)
Infection with human immunodeficiency virus (HIV). Infección por el virus de la inmunodeficiencia humana (VIH).
 
 
2004-000441-38: Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)

 
3/4
2
Europe
NA, NA, INVIRASE*270 CPS 200 MG, NORVIR*336 CPS MOLLI 100 MG, CRIXIVAN*180 CPS 400 MG, VIRACEPT*270 CPR 250 MG, FORTOVASE*180 CPS 200 MG, AGENERASE*240 CPS 150 MG, KALETRA*180 CPS BLISTER, VIRAMUNE*60 CPR 200 MG, SUSTIVA*90 CPS 200 MG, RETROVIR* 28 CPR 300 MG, VIDEX 400*30 CPS 400 MG, HIVID 0,750*100 CPR 0,750 MG, ZERIT 40*56 CPS 40 MG, EPIVIR*60 CPR 150 MG, COMBIVIR*60CPR BL 150/300MG, ZIAGEN*60 CPR RIV. 300 MG, TRIZIVIR*60 CPR RIV. BLISTER, VIREAD*30 CPR 245 MG, FUZEON*90MG/ML 60FL+60FL+60S
National Institute of Allergy and Infectious Diseases, National Institutes of Health, COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS
HIV infection
 
 

Download Options